NCT07143487
Family Communications After Genetic Testing
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial sites expanded: 360 → 365 locations
- Notable Eligibility criteria expanded, about 16 words
- Trial sites expanded: 319 → 360 locations
- Study description revised
- Minor Trial sites expanded: 299 → 319 locationsv6
- Minor Trial sites expanded: 276 → 299 locationsv5
- Minor Trial sites expanded: 242 → 276 locationsv4
Show 2 earlier versionsHide 2 earlier versions
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Nov 5, 2025 to Apr 6, 2026
- Study sites: 0 to 242
- Notable Primary completion date: Jan 31, 2029 to Nov 5, 2029
- Study completion date: Jan 31, 2030 to Nov 5, 2032
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Proportion of eligible first-degree relatives (FDRs) of the affected proband who underwent genetic testing
Timeframe: Within 6 months of proband randomization
Secondary (1)
Proportion of eligible FDRs with a PGV undergoing disease prevention efforts
Arms and interventions
Step 1 (biospecimen collection, genetic testing)Experimental
Probands undergo collection of blood samples and genetic testing on study.
Step 2, Arm A (proband-mediated)Active comparator
FDRs receive proband-mediated communication about the proband's genetic testing results.
Step 2, Arm B (provider-mediated)Experimental
FDRs receive provider-mediated communication about the proband's genetic testing results.
Procedures: Biospecimen Collection
Other: Genetic Testing, Communication Intervention, Survey Administration
Sites
365 sites in 2 countries
United States 358, Puerto Rico 7